Log Type | Authored on | Log Node | Authored by |
---|---|---|---|
Newsletter subscribed | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Fri, 08/14/2020 - 06:58 | Anonymous | |
Newsletter opened | Fri, 08/14/2020 - 06:08 | Anonymous | |
Newsletter subscribed | Wed, 10/12/2022 - 13:23 | Anonymous | |
User created | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter subscribed | Wed, 10/12/2022 - 13:23 | Anonymous | |
User created | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |
Newsletter subscribed | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Thu, 08/13/2020 - 19:14 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Estratégias na esquizofrenia - Aderente à adesão | Anonymous |
Newsletter clicked | Tue, 11/08/2022 - 12:04 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
Newsletter clicked | Tue, 11/08/2022 - 12:04 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
Newsletter subscribed | Wed, 10/12/2022 - 13:23 | Anonymous | |
User created | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |
Log Type | Authored on | Log Node | Authored by |
---|---|---|---|
Newsletter subscribed | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Fri, 08/14/2020 - 06:58 | Anonymous | |
Newsletter opened | Fri, 08/14/2020 - 06:08 | Anonymous | |
Newsletter subscribed | Wed, 10/12/2022 - 13:23 | Anonymous | |
User created | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter subscribed | Wed, 10/12/2022 - 13:23 | Anonymous | |
User created | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |
Newsletter subscribed | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Thu, 08/13/2020 - 19:14 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Estratégias na esquizofrenia - Aderente à adesão | Anonymous |
Newsletter clicked | Tue, 11/08/2022 - 12:04 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
Newsletter clicked | Tue, 11/08/2022 - 12:04 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
Newsletter subscribed | Wed, 10/12/2022 - 13:23 | Anonymous | |
User created | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Atualize-se com a Progress in Mind Brazil | Anonymous |